Zobrazeno 1 - 10
of 192
pro vyhledávání: '"Pier Franco Pignatti"'
Autor:
Oliviero Olivieri, Antonella Bassi, Chiara Stranieri, Elisabetta Trabetti, Nicola Martinelli, Francesca Pizzolo, Domenico Girelli, Simonetta Friso, Pier Franco Pignatti, Roberto Corrocher
Publikováno v:
Journal of Lipid Research, Vol 44, Iss 12, Pp 2374-2381 (2003)
Apolipoprotein C-III (apoC-III) is a marker of triglyceride (TG)-rich lipoproteins, which are often increased in metabolic syndrome (MS). The T−455C polymorphism in the insulin-responsive element of the APOC3 gene influences TG and apoC-III levels.
Externí odkaz:
https://doaj.org/article/0cd881c2a41541e39d21ff8d70e7fbfe
Autor:
Oliviero Olivieri, Chiara Stranieri, Antonella Bassi, Barbara Zaia, Domenico Girelli, Francesca Pizzolo, Elisabetta Trabetti, Suzanne Cheng, Michael A. Grow, Pier Franco Pignatti, Roberto Corrocher
Publikováno v:
Journal of Lipid Research, Vol 43, Iss 9, Pp 1450-1457 (2002)
Several polymorphisms in the apolipoprotein C-III (apoC-III) gene have been associated with hypertriglyceridemia, but the link with coronary artery disease risk is still controversial. In particular, apoC-III promoter sequence variants in the insulin
Externí odkaz:
https://doaj.org/article/6522f154239d40aa84e57a6f535bb57e
Autor:
Nicola Martinelli, Elisabetta Trabetti, Mirko Pinotti, Oliviero Olivieri, Marco Sandri, Simonetta Friso, Francesca Pizzolo, Claudia Bozzini, Pier Paolo Caruso, Ugo Cavallari, Suzanne Cheng, Pier Franco Pignatti, Francesco Bernardi, Roberto Corrocher, Domenico Girelli
Publikováno v:
PLoS ONE, Vol 3, Iss 2, p e1523 (2008)
BACKGROUND: Relative little attention has been devoted until now to the combined effects of gene polymorphisms of the hemostatic pathway as risk factors for Myocardial Infarction (MI), the main thrombotic complication of Coronary Artery Disease (CAD)
Externí odkaz:
https://doaj.org/article/7d4384faa9844d5f9ddcfee5c50d6f73
Autor:
Domenico Girelli, Nicola Martinelli, Oliviero Olivieri, Francesca Pizzolo, Simonetta Friso, Giovanni Faccini, Claudia Bozzini, Ilaria Tenuti, Valentina Lotto, Giuliano Villa, Patrizia Guarini, Elisabetta Trabetti, Pier Franco Pignatti, Alessandro Mazzucco, Roberto Corrocher
Publikováno v:
PLoS ONE, Vol 1, p e83 (2006)
BACKGROUND: The independent prognostic impact, as well as the possible causal role, of hyperhomocysteinemia (HHcy) in coronary artery disease (CAD) is controversial. No previous study specifically has addressed the relationship between HHcy and morta
Externí odkaz:
https://doaj.org/article/1294d9510ed34f34be6d40b96f3c6e6c
Autor:
Laura Saderi, Francesca Cherubino, Rosella Centis, Dina Visca, Antonio Spanevello, G. B. Migliori, Martina Zappa, Elisabetta Zampogna, G. Lo Bello, Pier Franco Pignatti, Nicolino Ambrosino, Giovanni Sotgiu
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 25:215-221
BACKGROUND: The 6‐min walking test (6MWT) is responsive to physiological changes and pulmonary rehabilitation (PR) in patients with asthma. The minimal clinically important difference (MCID) has not been established yet.OBJECTIVE: To determine the
Autor:
Giuseppe Faggian, Pier Franco Pignatti, Giovanni Malerba, Cristina Patuzzo, Alessandra Pasquali, Elisabetta Trabetti, Maddalena Tessari
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 51-55 (2012)
Balkan Journal of Medical Genetics : BJMG
Balkan Journal of Medical Genetics : BJMG
The development of thoracic aortic aneurysms (TAAs) involves a multifactorial process resulting in alterations of the structure and composition of the extracellular matrix (ECM). Recently, modifications in microRNA (miRNA) expression were implicated
Autor:
Jean Bousquet, Marie-Hélène Dizier, Jorge Esparza-Gordillo, Catherine Laprise, Florence Demenais, Emmanuelle Bouzigon, Valérie Siroux, Young-Ae Lee, Quentin B. Vincent, Giovanni Malerba, Liming Liang, William O.C.M. Cookson, Miriam F. Moffatt, Tomi Pastinen, Klaus Rohde, Patricia Margaritte-Jeannin, Pier Franco Pignatti, Andréanne Morin, Chloé Sarnowski, Mark Lathrop
Publikováno v:
Journal of Allergy and Clinical Immunology
Journal of Allergy and Clinical Immunology, Elsevier, 2016, 138 (3), pp.748-753. ⟨10.1016/j.jaci.2015.12.1341⟩
Journal of Allergy and Clinical Immunology, Elsevier, 2016, 138 (3), pp.748-753. ⟨10.1016/j.jaci.2015.12.1341⟩
International audience; BACKGROUND:Asthma and allergic rhinitis (AR) are common allergic comorbidities with a strong genetic component in which epigenetic mechanisms might be involved.OBJECTIVE:We aimed to identify novel risk loci for asthma and AR w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24bff413cd7c9c2afbd31574cd8c5cf2
https://hal.archives-ouvertes.fr/hal-01872256
https://hal.archives-ouvertes.fr/hal-01872256
Autor:
Michele Ramsay, Robert Williamson, Xavier Estivill, Brandon J. Wainwright, Meng-Falt Ho, Stephanie Halford, Juha Kere, Erkki Savilahti, Albert de la Chapelle, Marianne Schwartz, Martin Schwartz, Maurice Super, Peter Farndon, Carol Hardlng, Linda Meredith, Layla Al-Jader, Claude Ferec, Mirellle Claustres, Teresa Casals, Virginia Nunes, Paolo Gasparini, Anna Savoia, Pier Franco Pignatti, Giuseppe Novelli, Massimo Bennarelli, Bruno Dallapiccola, Luba Kalaydjieva, Peter J. Scambler
Publikováno v:
Scopus-Elsevier
Positional cloning involves first finding linkage between an inherited phenotype (such as a disease) and a DNA marker, followed by the use of a variety of physical and genetic mapping techniques to move from linkage to mutation. If there is a founder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db222f8243eb4dd163961fc1392f93d
https://ora.ox.ac.uk/objects/uuid:18ed8428-cbf7-41b9-bfda-cd94313251ad
https://ora.ox.ac.uk/objects/uuid:18ed8428-cbf7-41b9-bfda-cd94313251ad
Autor:
Fabiola Turrini, Maria Linda Boselli, Maddalena Trombetta, Pier Franco Pignatti, Riccardo C. Bonadonna, Enzo Bonora, Giovanni Malerba, Sara Bonetti, Elisabetta Trabetti
Publikováno v:
Diabetes Care. 34:1205-1210
OBJECTIVE In genome-wide association studies, performed mostly in nondiabetic individuals, genetic variability of glucokinase regulatory protein (GCKR) affects type 2 diabetes-related phenotypes, kidney function, and risk of chronic kidney disease (C